Medical research and development DHA sbir phase II proposal no. H2-0609 titled portable oculomotor and multi-sensing assessment system (pomas).
Ended Definitive Contract Awarded Last action
- Contract number
- W81XWH21C0031
- Awardee
-
Vistendo Inc. UEI QQE2AFWUGE67
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $1,649,979
Award facts
- Opportunity
-
- HQ003419R1DSB Solicitation number
- Contract value 100% obligated
- $1,649,979.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Medical Command Department of the Army, Department of Defense
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 17 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Arcadia, CA 91006, USA
- Research
- SBIR Program Phase II Action
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $549,993 | |
| Original award | $1,099,986 |
About this award
The Defense Health Agency awarded a $1.65M firm fixed-price definitive contract to Vistendo Inc., a minority-owned and woman-owned small business based in Arcadia, California, under the Small Business Innovation Research (SBIR) Program Phase II. The award, announced on March 15, 2021, is designated as a total small business set-aside and supports the development of the Portable Oculomotor and Multi-Sensing Assessment System (POMAS), an innovative medical research and development solution. The contract has an ultimate completion date of January 7, 2025, and represents a significant expansion of Vistendo's earlier Phase I SBIR effort, which was funded with a $249,960 purchase order in 2019 for initial POMAS research.
POMAS is designed to provide portable assessment and screening capabilities for medical evaluation, addressing Department of Defense research priorities in medical technology. This Phase II effort builds on the company's demonstrated capability in developing portable screening devices, including prior work on a Portable Early Impairment Screening Device. By leveraging the SBIR program's focus on fostering innovation within the small business community, the Defense Health Agency's investment in Vistendo supports the advancement of cutting-edge medical diagnostic and assessment technologies while promoting socioeconomic diversity in the defense industrial base.
Quick answers
Who was awarded contract W81XWH21C0031?
W81XWH21C0031 was awarded to Vistendo Inc. by Defense Health Agency (Department of Defense) on March 15, 2021.
How much is contract W81XWH21C0031 worth?
The government has obligated $1,649,979 on W81XWH21C0031.
Which agency awarded contract W81XWH21C0031?
Defense Health Agency (Department of Defense) awarded W81XWH21C0031, with funding from Medical Command (Department of the Army).
Was contract W81XWH21C0031 competed?
The extent of competition for W81XWH21C0031 was full and open competition after exclusion of sources. The government received 17 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award